Safety and Efficacy of Beclomethasone Dipropionate in Participants 4-11 Years Old With Persistent Asthma
- Study Title
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
- Teva Identifier
- BDB-AS-302 | 2013-004632-30
- ClinicalTrials.gov Identifier
- NCT02040766
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Beclomethasone dipropionate BAI | Drug: Placebo BAI | Drug: albuterol/salbutamol 90 mcg | Drug: Beclomethasone dipropionate MDI | Drug: Placebo MDI
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- 12/01/2013 - 03/01/2016
- Phase
- Phase 3